NCI Director Announces New Staff Appointments
NCI Director Dr. Harold Varmus recently announced staff appointments to several key positions in the institute.
Dr. James Doroshow has taken on a new role as NCI deputy director for Clinical and Translational Research. He had been the director of the Division of Cancer Treatment and Diagnosis (DCTD) since 2004, and he brings tremendous institutional and scientific knowledge about clinical investigation to his new position. DCTD will be jointly managed by current DCTD Deputy Director Dr. Joe Tomaszewski and DCTD Cancer Therapy Evaluation Program (CTEP) Director Dr. Jeff Abrams.
Dr. Barbara Wold will join NCI as director of the new Center for Cancer Genomics for a year while she is on leave from her position as Bren Professor of Molecular Biology and director of the Beckman Institute at the California Institute of Technology. A member of the Caltech faculty since 1981, Dr. Wold brings experience and insight from her work developing innovative tools in bioinformatics, such as RNA-Seq (a method for mapping and quantifying mammalian transcriptomes), and her discoveries in molecular genetics, genomics, and the regulation of cell fate. She will begin her new assignment on September 1.
Dr. Ted Trimble, head of Gynecological Cancer Therapeutics in CTEP, is serving as acting director for the new NCI Center for Global Health. He was instrumental in developing the trans-NCI International Clinical Trials Collaboration Working Group, and he has other global health experience that will be helpful in launching the new center.
Science Applications International Corporation (SAIC) has selected Dr. David Heimbrook as chief executive officer of SAIC-Frederick, Inc., an NCI partner. Dr. Heimbrook, previously the global head of discovery for the Oncology Discovery and Translation Area of Hoffman-LaRoche, Inc., began his new duties May 31.
Abstracts Sought for Annual Molecular Markers in Cancer Meeting
The Fifth EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer" will be held October 27–29 in Brussels, Belgium.
This year, the program will focus on challenges in biomarker development for clinical application in the age of multiplex testing and genome-wide screening. Topics also include molecular imaging, drug resistance, and emerging pathways for targeted therapeutics of novel molecular entities. Abstracts must be submitted by 8:00 a.m. ET on June 21.
A 2-day diagnostic development tutorial for early-career oncologists and scientists will precede the meeting. Early-career oncologists and scientists are eligible for a grant covering tutorial and meeting fees, lodging, and travel. The application deadline for the grant is June 15.
Research to Reality Cyber-Seminar Will Feature Community Impact Program
To mark National Survivorship Day, NCI's June 21 Research to Reality (R2R) cyber-seminar will highlight LIVESTRONG's Community Impact Project (CIP), an innovative approach for expanding the organization's community grants program. The seminar will explore the dissemination of one of LIVESTRONG's 2010 CIP survivorship programs, SuperSibs!
NCI Cancer Classroom Webinar Series Continues June 28
NCI's Office of Communications and Education is midway through a free, four-part webinar series, Cancer Classroom, for early-career public health professionals or those new to the field of oncology. This series provides the educational guidance, tools, and resources necessary for professionals to address cancer as a public health issue. The remaining sessions cover the clinical trials process.
The workshops are free, but preregistration for each session is required. To register or learn more, visit the NCI Cancer Classroom Series Web site. The remaining workshops will take place on Tuesdays from 2:00 p.m. to 3:30 p.m. ET on the following dates:
- June 28–Clinical Trials 101
- July 26–Clinical Trials 102
If you missed the first two sessions, view them online: